Evidence map›Paper›PMID 42006114›Full record

ReviewCurrent health sciences journal

Strength of Omics in Uncovering Sepsis Mechanisms-A Perspective.

Stefania Dorobantu, Andra Grigorescu, Andrian Fratea, Bogdan Mirauta, Adriana Neghina, George Bica, Adela Neacsu, Florentina Dumitrescu, Ioana Streata, Mihai Netea and 1 more

Abstract readReview
In one paragraph

Review in Current health sciences journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Stefania DorobantuGenomics Laboratory, Functional Genomics Group, University of Medicine and Pharmacy of Craiova, Romania.
Andra GrigorescuGenomics Laboratory, Functional Genomics Group, University of Medicine and Pharmacy of Craiova, Romania.
Andrian FrateaGenomics Laboratory, Functional Genomics Group, University of Medicine and Pharmacy of Craiova, Romania.
Bogdan MirautaGenomics Laboratory, Functional Genomics Group, University of Medicine and Pharmacy of Craiova, Romania.
Adriana NeghinaGenomics Laboratory, Functional Genomics Group, University of Medicine and Pharmacy of Craiova, Romania.
George BicaGenomics Laboratory, Functional Genomics Group, University of Medicine and Pharmacy of Craiova, Romania.
Adela NeacsuGenomics Laboratory, Functional Genomics Group, University of Medicine and Pharmacy of Craiova, Romania.
Florentina DumitrescuInfectious Disease Department, University of Medicine and Pharmacy of Craiova, Romania.
Ioana StreataGenomics Laboratory, Functional Genomics Group, University of Medicine and Pharmacy of Craiova, Romania.
Mihai NeteaGenomics Laboratory, Functional Genomics Group, University of Medicine and Pharmacy of Craiova, Romania.
Anca-Lelia RizaGenomics Laboratory, Functional Genomics Group, University of Medicine and Pharmacy of Craiova, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSepsis is a significant life-threatening condition due to a dysregulated response to infection. Large datasets yield unprecedented views and transformative insights into processes through various computational frameworks. Our aim was to highlight significant contributions from genomics, transcriptomics, proteomics in the field of sepsis, as modeled from human data. We are showcasing key findings in each omics that have improved the understanding of sepsis pathophysiology, while presenting a perspective from the group's own contribution to the field. DISCUSSION AND

conclusionsEach of the presented omics has advanced our mechanistic understanding on sepsis pathogenicity, biomarker identification for diagnosis, prognosis, and molecular stratification purposes. Multi-omics sepsis research shows strong input from genomics, transcriptomics, proteomics. These have revealed mechanistic links and produce robust endotypes but faces challenges on the path to clinical integration. Integrative sepsis studies combine large-scale omics, paired sampling, and computational multi-omics frameworks to link molecular layers to phenotype. Addressing gaps in standardization, and age/ethnicity representation could yield actionable biomarkers, stratified therapies and improved outcomes.

Indexed as

genomicsmetagenomicsOmicsproteomicssepsistranscriptomics

Identifiers

PMID42006114
PMCPMC13086478

What Socratic holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.